title: AKT-ing via microRNA.
abstract: MicroRNAs are involved in almost every aspect of a mammalian cell's functionality, from stem cell differentiation to aging and pathogenesis; however, their role in immediate cell signaling is less defined. This has been recently demonstrated by the rapid increase or decrease of miR-21's abundance within minutes of activation or inhibition of the AKT pathway, respectively, which mediates its regulation of Fas ligand (FasL) and phosphatase and tensin homologue deleted on chromosome 10 (PTEN) expression, among other targets. Conversely, AKT induces rapid downregulation of miR-199a-5p to effect upregulation of hypoxia-inducible factor 1α Hif-1α and sirtuin 1 (Sirt1). This suggests that posttranscriptional mechanisms regulate miRNAs' processing and/or stability to induce the rapid fluctuation in their levels. In support, a growing number of studies are showing specific posttranscriptional regulation of miRNAs. The data potentially explain how AKT, and plausibly other signaling pathways, can specifically and promptly modulate a gene's translation while circumventing the need for transcription during transient signaling events. In this article we present our views regarding cell signaling via miRNAs.
authors.affiliation: Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
authors.forename: Danish
authors.initials: D
authors.lastname: Sayed
authors.forename: Maha
authors.initials: M
authors.lastname: Abdellatif
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D053222:Fas Ligand Protein / Q000378:metabolism; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D035683:MicroRNAs / Q000378:metabolism* / Q000502:physiology; D017202:Myocardial Ischemia / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D015398:Signal Transduction; D056564:Sirtuin 1 / Q000378:metabolism; D013552:Swine / Q000378:metabolism
chemical_list: D053222:Fas Ligand Protein; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; C524940:MIRN21 microRNA, human; D035683:MicroRNAs; C531408:mirn199 microRNA, human; D051057:Proto-Oncogene Proteins c-akt; D056564:Sirtuin 1
references.citation: Circ Res. 2000 Aug 18;87(4):309-15
references.pmid: 10948065
references.citation: Cell Death Differ. 2005 Mar;12(3):233-42
references.pmid: 15665818
references.citation: Proc Natl Acad Sci U S A. 1993 May 1;90(9):4304-8
references.pmid: 8387214
references.citation: Nat Cell Biol. 2008 Aug;10(8):987-93
references.pmid: 18604195
references.citation: Circ Res. 2007 Jun 8;100(11):1579-88
references.pmid: 17478730
references.citation: Mol Cell Biol. 2002 Jan;22(2):680-91
references.pmid: 11756562
references.citation: J Biol Chem. 2009 Oct 23;284(43):29514-25
references.pmid: 19706597
references.citation: Brain Res. 2009 Aug 25;1286:13-8
references.pmid: 19559015
references.citation: J Biol Chem. 2008 Jan 11;283(2):1026-33
references.pmid: 17991735
references.citation: Science. 2001 Nov 9;294(5545):1337-40
references.pmid: 11598268
references.citation: Cancer Res. 2010 Mar 15;70(6):2339-49
references.pmid: 20215506
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7113-8
references.pmid: 19359473
references.citation: Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4218-23
references.pmid: 20142475
references.citation: Cell Signal. 2010 Jul;22(7):1054-62
references.pmid: 20193759
references.citation: Nat Cell Biol. 2009 Jul;11(7):881-9
references.pmid: 19543271
references.citation: Nature. 1999 May 20;399(6733):271-5
references.pmid: 10353251
references.citation: Circulation. 1986 Nov;74(5):1124-36
references.pmid: 3769170
references.citation: Leukemia. 2008 Jan;22(1):147-60
references.pmid: 17928881
references.citation: Genes Chromosomes Cancer. 2008 Nov;47(11):939-46
references.pmid: 18663744
references.citation: Genes Dev. 2009 Feb 15;23(4):433-8
references.pmid: 19240131
references.citation: Oncogene. 2008 Apr 3;27(15):2128-36
references.pmid: 17968323
references.citation: Cancer Res. 2008 Oct 1;68(19):7846-54
references.pmid: 18829540
references.citation: Am J Physiol Heart Circ Physiol. 2006 May;290(5):H2116-23
references.pmid: 16339840
references.citation: Nature. 2009 Jun 18;459(7249):1010-4
references.pmid: 19458619
references.citation: FASEB J. 2009 Sep;23(9):2898-908
references.pmid: 19423639
references.citation: Cardiovasc Res. 2010 Aug 1;87(3):431-9
references.pmid: 20219857
references.citation: Clin Exp Pharmacol Physiol. 2009 Sep;36(9):e32-9
references.pmid: 19473196
references.citation: Oncogene. 2003 Oct 23;22(48):7617-27
references.pmid: 14576824
references.citation: Gastroenterology. 2007 Aug;133(2):647-58
references.pmid: 17681183
references.citation: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003 Nov;147(1):19-25
references.pmid: 15034601
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19300-5
references.pmid: 19033458
references.citation: Circ Res. 2009 Mar 13;104(5):572-5
references.pmid: 19213952
references.citation: Nature. 2008 Jul 3;454(7200):56-61
references.pmid: 18548003
references.citation: J Biol Chem. 2010 May 28;285(22):16958-66
references.pmid: 20371612
references.citation: J Biol Chem. 2010 Jun 25;285(26):20281-90
references.pmid: 20404348
references.citation: Mol Cell. 2008 Nov 7;32(3):383-93
references.pmid: 18995836
references.citation: J Biol Chem. 2007 May 11;282(19):14328-36
references.pmid: 17363372
references.citation: Cancer Cell. 2009 Dec 8;16(6):498-509
references.pmid: 19962668
references.citation: J Surg Res. 1997 Aug;71(2):155-60
references.pmid: 9299284
references.citation: Gastroenterology. 2006 Jun;130(7):2113-29
references.pmid: 16762633
references.citation: Circ Res. 2009 Apr 10;104(7):879-86
references.pmid: 19265035
references.citation: Blood. 2009 Oct 8;114(15):3265-75
references.pmid: 19641183